IL-4 production is observed in trials as mentioned following COVID-19 vaccination, whereas data about IL-17 and IL-21 which are viewed as the protective factor of vaccine-induced immunity, are still missing in patients developing pemphigus following COVID-19 vaccine administration [49,50]. Here, IL17A is linked to COVID-19.